Mirum Pharmaceuticals, Inc. (MIRM)
95.52
+1.93
(+2.06%)
USD |
NASDAQ |
Jun 09, 16:00
95.52
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Profit Margin (Quarterly) : -494.2% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 13.55% |
| Incyte Corp. | 23.83% |
| Ionis Pharmaceuticals, Inc. | -37.60% |
| Travere Therapeutics, Inc. | -28.78% |
| Vertex Pharmaceuticals, Inc. | 34.24% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -298.6% |
| Return on Assets | -101.5% |
| Return on Invested Capital | -136.1% |
| Gross Profit Margin (Quarterly) | 81.94% |
| Operating Margin (Quarterly) | -39.51% |
| Return on Net Operating Assets | -202.8% |